Midkine and Melanoma Metastasis: A Malevolent Mix
- PMID: 28787586
- DOI: 10.1016/j.devcel.2017.07.015
Midkine and Melanoma Metastasis: A Malevolent Mix
Abstract
Using an in vivo reporter for lymphangiogenesis, a recent study in Nature from Olmeda et al. (2017) describes a new subset of melanomas that induce systemic pre-conditioning of distant organs for formation of tumor metastatic niches, and identifies the responsible factor as the pleiotropic cytokine midkine.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.Nature. 2017 Jun 28;546(7660):676-680. doi: 10.1038/nature22977. Nature. 2017. PMID: 28658220 Free PMC article.
Similar articles
-
Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.Nature. 2017 Jun 28;546(7660):676-680. doi: 10.1038/nature22977. Nature. 2017. PMID: 28658220 Free PMC article.
-
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.Am J Pathol. 2003 Jun;162(6):1951-60. doi: 10.1016/S0002-9440(10)64328-3. Am J Pathol. 2003. PMID: 12759251 Free PMC article.
-
Tumor lymphangiogenesis and melanoma metastasis.J Cell Physiol. 2008 Aug;216(2):347-54. doi: 10.1002/jcp.21494. J Cell Physiol. 2008. PMID: 18481261 Review.
-
Angiogenesis and lymphangiogenesis of skin cancers.Hematol Oncol Clin North Am. 2004 Oct;18(5):1059-70, viii. doi: 10.1016/j.hoc.2004.06.009. Hematol Oncol Clin North Am. 2004. PMID: 15474335 Review.
-
Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.Int J Surg Pathol. 2015 Dec;23(8):629-37. doi: 10.1177/1066896915583694. Epub 2015 Apr 24. Int J Surg Pathol. 2015. PMID: 25911567
Cited by
-
Midkine is a dual regulator of wound epidermis development and inflammation during the initiation of limb regeneration.Elife. 2020 Jan 14;9:e50765. doi: 10.7554/eLife.50765. Elife. 2020. PMID: 31934849 Free PMC article.
-
Multifunctional nanomaterials composed entirely of active pharmaceutical ingredients for synergistically enhanced antitumor and antibacterial effects.Front Pharmacol. 2024 Oct 21;15:1498728. doi: 10.3389/fphar.2024.1498728. eCollection 2024. Front Pharmacol. 2024. PMID: 39498338 Free PMC article.
-
Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics.EMBO Mol Med. 2021 Dec 7;13(12):e12924. doi: 10.15252/emmm.202012924. Epub 2021 Nov 11. EMBO Mol Med. 2021. PMID: 34762341 Free PMC article.
-
Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target.Oncogene. 2020 Mar;39(10):2040-2054. doi: 10.1038/s41388-019-1124-8. Epub 2019 Dec 4. Oncogene. 2020. PMID: 31801970 Review.
-
Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma.Front Oncol. 2022 Mar 8;12:844666. doi: 10.3389/fonc.2022.844666. eCollection 2022. Front Oncol. 2022. PMID: 35345444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
